Iseu da Silva Nunes

A graduated in Business Administration and Law, specialized in Sustainable Development and Environmental Management , Drug Development and Intelectual Property.He has participated in research groups in Brazil (São Paulo State University Unesp; Campinas State University Unicamp; São Paulo University USP; Butantan Institute; Federal University of Pernambuco UFPE; Oswaldo Cruz Foundation - Fiocruz), in the UK (University of Oxford), and in the US (NIAID/NIH; Utah State University, Colorado State University), Stop TB Partnerships (StopTB) to develop new drugs to treat cancer and infectious diseases.As a CEO of the research network Farmabrasilis, he runs the basic and applied research on the immunomodulator P-MAPA, in final developmen (Source: Lattes Curriculum)